TABLE 3.
Guidelines, year (reference) | HCV coinfection | Class/Grade of evidence |
---|---|---|
IAS-USA Guidelines, 2012 (66) | ART regardless of CD4 cell count | BIIa |
US DHHS Guidelines, 2012 (67) | ART regardless of CD4 cell count | BII |
British HIV Association Guidelines, 2012 (68) | ART if CD4 count <500 cells/μL | IC |
European AIDS Clinical Society Guidelines, 2012 (69) | ART if CD4 count <500 cells/μL; ≥500 cells/μL: consider ART if HCV therapy not feasible |
ART Antiretroviral therapy; IAS-USA International Antiviral Society – United States; US DHHA United States Department of Health and Human Services